Variant report
Variant | nsv969448 |
---|---|
Chromosome Location | chr6:133188967-133190432 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:1)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
(count:1 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-C6orf192-2 | chr6:133189357-133189998 | NONHSAT114983 |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs572356357 | chr6:133188976-133188977 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs541380241 | chr6:133188977-133188978 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs564443607 | chr6:133189025-133189026 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs34698096 | chr6:133189030-133189031 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs533443425 | chr6:133189069-133189070 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs550141083 | chr6:133189141-133189142 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs563531537 | chr6:133189167-133189168 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs563565778 | chr6:133189198-133189199 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs549269343 | chr6:133189199-133189200 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs565993693 | chr6:133189225-133189226 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs530942157 | chr6:133189230-133189231 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs527305507 | chr6:133189237-133189238 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs547343305 | chr6:133189248-133189249 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs570483894 | chr6:133189326-133189327 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs143606539 | chr6:133189361-133189362 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
16 | rs373793447 | chr6:133189372-133189373 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
17 | rs34987255 | chr6:133189374-133189375 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
18 | rs138851027 | chr6:133189452-133189453 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
19 | rs570963073 | chr6:133189456-133189457 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
20 | rs149371366 | chr6:133189477-133189478 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
21 | rs569866485 | chr6:133189489-133189490 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
22 | rs73545946 | chr6:133189494-133189495 | Weak transcription Enhancers | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
23 | rs76741607 | chr6:133189517-133189518 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
24 | rs147519164 | chr6:133189549-133189550 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
25 | rs78480943 | chr6:133189593-133189594 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
26 | rs558116695 | chr6:133189594-133189595 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
27 | rs558498376 | chr6:133189597-133189598 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
28 | rs76868538 | chr6:133189600-133189601 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
29 | rs578089023 | chr6:133189638-133189639 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
30 | rs140048662 | chr6:133189721-133189722 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
31 | rs543507826 | chr6:133189726-133189727 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
32 | rs563395861 | chr6:133189775-133189776 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
33 | rs74709990 | chr6:133189797-133189798 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
34 | rs541037519 | chr6:133189821-133189822 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
35 | rs546519867 | chr6:133189849-133189850 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
36 | rs542780409 | chr6:133189870-133189871 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
37 | rs144118191 | chr6:133189896-133189897 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
38 | rs188523724 | chr6:133189897-133189898 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
39 | rs547114811 | chr6:133189907-133189908 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
40 | rs570421950 | chr6:133189930-133189931 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
41 | rs568242410 | chr6:133189989-133189990 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
42 | rs549908756 | chr6:133190048-133190049 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs569731286 | chr6:133190063-133190064 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs192946316 | chr6:133190065-133190066 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs535413921 | chr6:133190081-133190082 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs555577651 | chr6:133190098-133190099 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs565868124 | chr6:133190161-133190162 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs534907718 | chr6:133190167-133190168 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs147313747 | chr6:133190199-133190200 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Biliary cancer | 19435499 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Malaria | 21533027 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Autism | 21448237 | CNVD |
Autism | 22495311 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Gastric cancer | 17908304 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 19010834 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 16608533 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Prostate cancer | 16705090 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Ependymoma | 16718352 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 16272173 | CNVD |
Prostate cancer | 18632612 | CNVD |
Wilms tumour | 21544195 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Glioma | 21046410 | CNVD |
Primary central nervous system lymphoma | 21088137 | CNVD |
Zellweger syndrome | 21572526 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Malignant melanoma | 18718029 | CNVD |
Lung adenocarcinoma | 21935476 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 21858162 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Breast cancer | 17603634 | CNVD |
Chondromyxoid Fibroma | 20696777 | CNVD |
Cancer | 21183584 | CNVD |
Developmental delay | 19490664 | CNVD |
Non-muscle invasive bladder neoplasm | 19445696 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Breast cancer | 21785460 | CNVD |
Kartagener syndrome | 16639409 | CNVD |
Breast cancer | 17133270 | CNVD |
Follicular lymphoma | 18703704 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Leukemia | 18688285 | CNVD |
Breast cancer | 21364760 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:133187800-133189000 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
2 | chr6:133187800-133190200 | Enhancers | Fetal Heart | heart |
3 | chr6:133188200-133189000 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
4 | chr6:133188200-133189000 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
5 | chr6:133188800-133189800 | Weak transcription | H9 Derived Neuron Cultured Cells | ES cell derived |
6 | chr6:133189000-133189400 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
7 | chr6:133189400-133189800 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
8 | chr6:133189800-133190200 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |